John Jureller - Amer Renal Independent Director

Director

Mr. John M. Jureller is an Independent Director of the Company, Mr. Jureller also serves on the board of directors of White Plains Hospital and is the chairman of the finance committee as well as a member of the audit committee of the board of directors of White Plains Hospital. Mr. Jureller served on the audit committees of Studio Moderna Holdings B.V. from 2011 to 2012 and Torex Retail Holdings Ltd. from 2009 to 2012. Mr. Jureller is currently the executive vice president and chief financial officer of Frontier Communications Corporationration Prior to joining Frontier Communications Corporationration in 2013, Mr. Jureller served in a variety of senior financial roles with various companies including General Atlantic LLC, WestPoint International, Inc., AlixPartners, LLP, PepsiCo, Inc. and General Electric Capital Corporationrationration. Mr. Jureller began his career with the corporate banking and leveraged finance groups at Bankers Trust Company since 2015.
Age 59
Tenure 9 years
Professional MarksMBA
Phone978 922-3080
Webwww.americanrenal.com
Jureller received a B.S. in Finance and an M.B.A. from Cornell University.

Amer Renal Management Efficiency

The company has Return on Asset of 4.35 % which means that on every $100 spent on assets, it made $4.35 of profit. This is considered to be average in the sector. In the same way, it shows a return on shareholders' equity (ROE) of 17.51 %, implying that it generated $17.51 on every 100 dollars invested. Amer Renal's management efficiency ratios could be used to measure how well Amer Renal manages its routine affairs as well as how well it operates its assets and liabilities.
The company has 724.51 M in debt with debt to equity (D/E) ratio of 3.94, meaning that the company heavily relies on borrowing funds for operations. Amer Renal Assoc has a current ratio of 1.03, demonstrating that it is in a questionable position to pay out its financial commitments when the payables are due. Debt can assist Amer Renal until it has trouble settling it off, either with new capital or with free cash flow. So, Amer Renal's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Amer Renal Assoc sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Amer to invest in growth at high rates of return. When we think about Amer Renal's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

DIRECTOR Age

Herbert SimonThe Cheesecake Factory
83
Richard PorterHurco Companies
62
Jay LongbottomHurco Companies
64
Robert CruickshankHurco Companies
72
Ronald StrackbeinHurco Companies
73
Wesley BartonEl Pollo Loco
36
Paul GordonArk Restaurants Corp
73
Gilbert RayDine Brands Global
75
Edie AmesThe Cheesecake Factory
51
Mark BullerEl Pollo Loco
53
Larry KayDine Brands Global
73
Sidney FeltensteinWingstop
75
Dean KehlerEl Pollo Loco
61
Kilandigalu MadatiWingstop
44
Krishnan AnandWingstop
60
Thomas AaroHurco Companies
60
Anthony SiricaArk Restaurants Corp
54
Vincent PascalArk Restaurants Corp
81
David GoebelWingstop
67
Carol LyntonEl Pollo Loco
56
Erik MorrisWingstop
39
American Renal Associates Holdings, Inc. operates as a dialysis services provider in the United States. The company was founded in 1999 and is headquartered in Beverly, Massachusetts. American Renal operates under Diagnostics Research classification in the United States and is traded on New York Stock Exchange. It employs 4977 people. Amer Renal Assoc (ARA) is traded on New York Stock Exchange in USA and employs 4,977 people.

Management Performance

Amer Renal Assoc Leadership Team

Elected by the shareholders, the Amer Renal's board of directors comprises two types of representatives: Amer Renal inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Amer. The board's role is to monitor Amer Renal's management team and ensure that shareholders' interests are well served. Amer Renal's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Amer Renal's outside directors are responsible for providing unbiased perspectives on the board's policies.
Jason Boucher, Chief Accounting Officer, Vice President - Finance, Treasurer
Steven Silver, Independent Director
Patrick Ryan, Independent Director
Thomas Erickson, Independent Director
John Jureller, Independent Director
Jonathan Wilcox, CFO, Vice President
Michael Costa, Vice President General Counsel, Secretary
Robert Fish, Independent Director
Joseph Carlucci, Chairman of the Board, Chief Executive Officer, Co-Founder
Jeremy Gelber, Independent Director
Don Williamson, Chief Operating Officer, Executive Vice President
Christopher Hocevar, Independent Director
Syed Kamal, President, Co-Founder, Director
Jared Hendricks, Independent Director
John McDonough, COO, Executive Vice President Treasurer
Michael Boxer, Independent Director
Susanne Clark, Independent Director
Mark Herbers, Interim Chief Financial Officer, Interim Chief Accounting Officer

Amer Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Amer Renal a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Pair Trading with Amer Renal

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Amer Renal position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amer Renal will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to Microsoft could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Microsoft when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Microsoft - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Microsoft to buy it.
The correlation of Microsoft is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Microsoft moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Microsoft moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Microsoft can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.

Other Consideration for investing in Amer Stock

If you are still planning to invest in Amer Renal Assoc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Amer Renal's history and understand the potential risks before investing.
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories